Actively Recruiting
Feasibility Study of the VERAFEYE Imaging and Navigation System in Guiding Catheter Ablation for Atrial Flutter and Atrial Fibrillation
Led by LUMA Vision Ltd. · Updated on 2026-11-03
50
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the VERAFEYE Imaging and Guidance System in adults scheduled for standard catheter-based ablation procedures to treat atrial flutter, paroxysmal atrial fibrillation, or persistent atrial fibrillation. The study aims to collect data on how usable and well integrated the VERAFEYE system is during these procedures. The findings may help improve the systems capabilities for future use. Participants will receive catheter-based ablation treatments for atrial flutter andor atrial fibrillation as part of their standard care. During these procedures, the VERAFEYE Imaging and Guidance System will be used to assist the treatment. The study focuses on observing the systems performance throughout the procedure and any adverse device effects within 7 days after the procedure. Throughout the study, participants will undergo assessments related to the performance of the VERAFEYE system during their ablation procedure. Safety monitoring will include tracking any adverse device effects within the week following the procedure. Participants must provide informed consent and be willing to complete all study assessments at an approved site. The total participation period aligns with the procedure and immediate post-procedure monitoring.
CONDITIONS
Brief Title
Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures
Research Team
I
Ivan Sikiric
I
Ivan Aranza
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here